Filing Details
- Accession Number:
- 0001371285-25-000108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-24 18:27:50
- Reporting Period:
- 2025-03-20
- Filing Date:
- 2025-03-24
- Accepted Time:
- 2025-03-24 18:27:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657025 | Margaret Tooth | C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-20 | 4,000 | $8.93 | 122,784 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-20 | 4,000 | $37.18 | 118,784 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2025-03-20 | 4,000 | $0.00 | 4,000 | $8.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,000 | 2025-12-21 | No | 4 | M | Direct |
Footnotes
- The sale reported is effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 29, 2024, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9600 to $37.4100 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- This stock option grant is fully vested.
Billionaire Hedge Funds
